Home / Environment / Metagenomics Analysis Market By Product (Kits & Reagents and Data Analytics), By Technology (Function Driven and Sequencing Driven), By Application (Environmental, Human Health and Others) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

Metagenomics Analysis Market By Product (Kits & Reagents and Data Analytics), By Technology (Function Driven and Sequencing Driven), By Application (Environmental, Human Health and Others) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

Published: Mar 2019 | Published By: Acute Market Reports

The metagenomics analysis market is set to reach from US$ 374.6 Mn in 2017 to US$ 1,505.7 Mn in 2026 highlighting rampant growth at a compounded annual growth rate of 16.9% during the forecast period from 2018 to 2026. Increasing demand for microbial screening in food and chemical industry and significant increase in the bioinformatics segment drive the metagenomic analysis market growth.

"Increasing adoption rate and rising demand from research laboratories for library preparation kits to enhance workflow drive the kits & reagents market growth"

Kits and reagents are the largest market in product segment for metagenomic analysis market. The key factors consolidating its market growth are increasing adoption rate and rising demand from research laboratories for library preparation kits to enhance workflow. Data analytics will grow at a steady pace during the forecast period on account of development of software tools and solutions pertaining to microbiome datasets featuring latest sequencing technologies and increased compatibility.

"Advent of bioinformatics related solutions and burgeoning requirement for the development of genomic data repository consolidates the sequencing driven market growth"

Sequencing driven technology is leading the metagenomic analysis market. It is widely adopted for the diagnosis of infectious diseases and characterization of human gut microbes. The recent advent of bioinformatics related solutions and increasing demand for the development of genomic data repositories drive the function driven technology market growth. Function driven technology is gaining positive traction in biotechnology industry for its ability in screening of proteins, vitamins and antibiotic resistance. This technique is also widely employed in understanding the biodegradation of organophosphorus molecules and estimate its degradation potential.

"Increasing demand for screening uncultured microbes and bioremediation drive the environmental applications market growth"

Environmental applications are reigning the metagenomics analysis market growth. The metagenomics analytical studies are widely adopted to understand the impact of anthropogenic activites on the surrounding ecology. The ability to screen uncultured microbes and perform bioremediation drive the environmental application market growth. Human health applications will register impressive growth in the near future owing to the increasing adoption of metagenomic analysis in epidemiological studies and high throughput screening stage of drug discovery and development. 

"Increasing environmental degradation and rising public health awareness drive the market growth in North America"

North America is dominating the regional segment for metagenomics analysis market with a share of 39%. The major attributes influencing its market growth are rising public health awareness and increasing environmental degradation. Domicile of key players such as Agilent Technologies, QIAGEN, Thermo Fisher Scientific, Inc., etc. bolster the metagenomics analysis market growth in North America region. Europe is the second largest market accounting for 26% market share on account for increasing demand for agricultural produce and significant increase in research and development sector for the development of biofuel. Asia Pacific holds 17% market share owing to rampant growth in biotechnology industry and proactive government initiatives in developing bioinformatics framework to concentrate on research activites pertaining to human health.

Historical & Forecast Period

This research report presents the analysis of each segment from 2016 to 2026 considering 2017 as the base year for the research. Compounded annual growth rate (CAGR) for each respective segments are calculated for the forecast period from 2018 to 2026

Report Scope by Segments

Metagenomics analysis market segmentation is as follows: 

ATTRIBUTE DETAILS
Research Period  2016-2026
Base Year 2017
Forecast Period  2018-2026
Historical Year  2016
Unit  USD Million
Segmentation

 By Product (2016–2026; US$ Mn)
 • Kits & Reagents
 • Data Analytics

 By Technology (2016–2026; US$ Mn)
 • Function Driven
 • Sequencing Driven

 By Application (2016–2026; US$ Mn)
 • Environmental
 • Human Health
 • Others

 Geography Segment (2016–2026; US$ Mn)
 • North America (U.S., Canada)
 • Europe (U.K., Germany, Rest of Europe)
 • Asia Pacific (China, Japan, Rest of Asia Pacific)
 • Latin America (Brazil, Mexico, Rest of Latin America)
 • Middle East and Africa (GCC, Rest of MEA)

Biotechnology companies providing metagenomics analysis are Agilent, Technologies, Bio-Rad Laboratories, Inc., Illumina, Inc., Luminex Corporation, Novogene Corporation, Promega Corporation, PerkinElmer, Inc., QIAGEN, Takara Bio, Inc. and Thermo Fisher Scientific, Inc.

Key questions answered in this report

  • Which biotechnology companies are actively engaged in the metagenomics analysis market?
  • What are the latest technological advancement taking place in the metagenomics analysis market?
  • Which major factors are responsible for the impressive growth of reagents and kits in the products segment?
  • What is the importance of function driven and sequencing driven technology in metagenomic analysis?
  • How is metagenomic analysis applied for bioremediation and biofuel generation?
  • Why is North America the leading regional segment in metagenomics analysis market?

Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Approach Adopted
1.3.4. Top-down Approach
1.3.5. Bottom-up Approach
1.3.6. Phase III-Expert Panel Review
1.3.7. Assumptions
1.4. Market Segmentation

Chapter 2. Executive Summary
2.1. Global MA Market Portraiture
2.2. Global MA Market, by Product, 2017 (US$ Mn)
2.3. Global MA Market, by Technology, 2017 (US$ Mn)
2.4. Global MA Market, by Application, 2017 (US$ Mn)
2.5. Global MA Market, by Geography, 2017 (US$ Mn)

Chapter 3. Metagenomics Analysis (MA) Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global MA Market, by Key Players, 2017

Chapter 4. Global Metagenomics Analysis (MA) Market, by Product
4.1. Overview
4.2. Kits & Reagents
4.3. Data Analytics

Chapter 5. Global Metagenomics Analysis (MA) Market, by Technology
5.1. Overview
5.2. Function Driven
5.3. Sequencing Driven

Chapter 6. Global Metagenomics Analysis (MA) Market, by Application
6.1. Overview
6.2. Environmental
6.3. Human Health
6.4. Others

Chapter 7. Global Metagenomics Analysis (MA) Market, by Geography
7.1. Overview
7.2. North America MA Market Analysis, 2016 – 2026
7.2.1. North America MA Market, by Product, 2016 – 2026 (US$ Mn)
7.2.2. North America MA Market, by Technology, 2016 – 2026 (US$ Mn)
7.2.3. North America MA Market, by Application, 2016 – 2026 (US$ Mn)
7.2.4. North America MA Market, by Country, 2016 – 2026 (US$ Mn)
7.2.4.1. U.S.
7.2.4.2. Canada
7.3. Europe MA Market Analysis, 2016 – 2026
7.3.1. Europe MA Market, by Product, 2016 – 2026 (US$ Mn)
7.3.2. Europe MA Market, by Technology, 2016 – 2026 (US$ Mn)
7.3.3. Europe MA Market, by Application, 2016 – 2026 (US$ Mn)
7.3.4. Europe MA Market, by Country/Region, 2016 – 2026 (US$ Mn)
7.3.4.1. U.K.
7.3.4.2. Germany
7.3.4.3. Rest of Europe
7.4. Asia Pacific MA Market Analysis, 2016 – 2026
7.4.1. Asia Pacific MA Market, by Product, 2016 – 2026 (US$ Mn)
7.4.2. Asia Pacific MA Market, by Technology, 2016 – 2026 (US$ Mn)
7.4.3. Asia Pacific MA Market, by Application, 2016 – 2026 (US$ Mn)
7.4.4. Asia Pacific MA Market, by Country/Region, 2016 – 2026 (US$ Mn)
7.4.4.1. China
7.4.4.2. Japan
7.4.4.3. Rest of Asia Pacific
7.5. Latin America MA Market Analysis, 2016 – 2026
7.5.1. Latin America MA Market, by Product, 2016 – 2026 (US$ Mn)
7.5.2. Latin America MA Market, by Technology, 2016 – 2026 (US$ Mn)
7.5.3. Latin America MA Market, by Application, 2016 – 2026 (US$ Mn)
7.5.4. Latin America MA Market, by Country/Region, 2016 – 2026 (US$ Mn)
7.5.4.1. Brazil
7.5.4.2. Mexico
7.5.4.3. Rest of Latin America
7.6. Middle East and Africa MA Market Analysis, 2016 – 2026
7.6.1. MEA MA Market, by Product, 2016 – 2026 (US$ Mn)
7.6.2. MEA MA Market, by Technology, 2016 – 2026 (US$ Mn)
7.6.3. MEA MA Market, by Application, 2016 – 2026 (US$ Mn)
7.6.4. MEA MA Market, by Country/Region, 2016 – 2026 (US$ Mn)
7.6.4.1. GCC
7.6.4.2. Rest of MEA

Chapter 8. Company Profiles
8.1. Agilent Technologies
8.1.1. Business Description
8.1.2. Financial Information (Subject to data availability)
8.1.3. Product Portfolio
8.1.4. News Coverage
8.2. Bio-Rad Laboratories, Inc.
8.3. Illumina, Inc.
8.4. Luminex Corporation
8.5. Novogene Corporation
8.6. Promega Corporation
8.7. PerkinElmer, Inc.
8.8. QIAGEN
8.9. Takara Bio, Inc.
8.10. Thermo Fisher Scientific, Inc.

* MA - Metagenomics Analysis

Choose License Type
 
Contact Information
24/7 Research Support
Phone: +1-855-455-8662
sales@acutemarketreports.com
Get in Touch with us
join us on Facebook
Follow us on Twitter
Follow us on LinkedIn
Add us on Google +